Paid Clinical Trials New Braunfels
Discover 1,308 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Netarsudil vs. BrimonidineEffect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
Sponsor:
Westlake Eye Specialists
Location:
Code:
NCT06449352
Conditions
Normal Tension Glaucoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Netarsudil
Brimonidine
Elacestrant vs. Standard Endocrine TherapyA Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor:
Stemline Therapeutics, Inc.
Location:
Code:
NCT06492616
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elacestrant
Anastrozole
Letrozole
Exemestane
Tamoxifen
VivAer vs. Alternative Surgical ProceduresA Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
Sponsor:
Aerin Medical
Location:
Code:
NCT06922955
Conditions
Nasal Airway Obstruction
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Bria-IMT Regimen & CPIStudy of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Sponsor:
BriaCell Therapeutics Corporation
Location:
Code:
NCT06072612
Conditions
Breast Cancer
Metastatic Breast Cancer
Breast Neoplasm
Breast Cancer Metastatic
End Stage Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SV-BR-1-GM
Cyclophosphamide
Interferon infiltration of the inoculation site
Retifanlimab
Treatment of Physician's Choice
FaricimabA Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT06795048
Conditions
Neovascular Age-related Macular Degeneration (nAMD)
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Faricimab
CagriSemaA Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT07011667
Conditions
Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CagriSema (Cagrilintide B and Semaglutide I)
Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)
PDS with RanibizumabA Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration(nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Sponsor:
Genentech, Inc.
Location:
Code:
NCT04853251
Conditions
Neovascular Age-related Macular Degeneration
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
SUSVIMO PDS Implant
LUCENTIS (ranibizumab injection)
RO7497372A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
Sponsor:
Genentech, Inc.
Location:
Code:
NCT06847854
Conditions
Diabetic Macular Edema
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RO7497372